ROBITET Drug Patent Profile
✉ Email this page to a colleague
When do Robitet patents expire, and when can generic versions of Robitet launch?
Robitet is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in ROBITET is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Robitet
A generic version of ROBITET was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROBITET?
- What are the global sales for ROBITET?
- What is Average Wholesale Price for ROBITET?
Summary for ROBITET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 240 |
| DailyMed Link: | ROBITET at DailyMed |
US Patents and Regulatory Information for ROBITET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ROBITET | tetracycline hydrochloride | CAPSULE;ORAL | 061734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Wyeth Ayerst | ROBITET | tetracycline hydrochloride | CAPSULE;ORAL | 061734-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
